Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC-MS-MS

Journal of Analytical Toxicology

Volumn 36, Issue 5, 2012, Pages 319-326

  Ruiz Colón, Kazandra ^a,b   Martínez, María A ^c   Silva Torres, Luz A ^a,b   Chavez Arias, Carlos ^a   Meléndez Negrón, Margarita ^a   Conte Miller, María S ^a   Bloom Oquendo, Joseph ^b  

^a Institute of Forensic Sciences of Puerto Rico   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c Biology Section Apdo 863 E 41080   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; CODEINE; MORPHINE; MORPHINE 6 ACETATE; XYLAZINE; 6-O-MONOACETYLMORPHINE; DIAMORPHINE; DRUG DERIVATIVE; MORPHINE DERIVATIVE; STREET DRUG;

ARTICLE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS; BLOOD; CHEMISTRY; DRUG CONTAMINATION; ELECTROSPRAY MASS SPECTROMETRY; FORENSIC PATHOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; REPRODUCIBILITY; SUBSTANCE ABUSE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CODEINE; DRUG CONTAMINATION; FORENSIC PATHOLOGY; HEROIN; HUMANS; MORPHINE; MORPHINE DERIVATIVES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; XYLAZINE;

EID: 84865838919     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks024     Document Type: Article

References (33)

1. Stillwell, M.E. (2003) A reported case involving impaired driving following self-administration of Xylazine. Forensic Science International, 24, 25-28.
2. Barroso, M., Gallardo, E., Margalho, C., Devesa, N., Pimentel, J., Vieira, D.N. (2007) Solid-phase extraction and gas chromatographic- mass spectrometric determination of the veterinary drug xylazine in human blood. Journal of Analytical Toxicology, 31, 165-169.
3. Mittleman, R.E., Hearn, W.L., Hime, G.W. (1998) Xylazine toxicity- Literature review and report of two cases. Journal of Forensic Sciences, 43, 400-402.
4. Elejalde, J.I., Louis, C.J., Elcuaz, R., Pinillos, M.A. (2003) Drug abuse with inhalated xylazine. European Journal of Emergency Medicine, 10, 252-253.
5. Liu, C-M., Chiu, M-J., Fang, C-C. (2007) Xylazine abuse: A rare cause of syncope. Clinical Toxicology, 45, 309-311.
6. Hoffmann, U., Meister, C.M., Golle, K., Zschiesche, M. (2001) Severe intoxication with the veterinary tranquilizer xylazine in humans. Journal of Analytical Toxicology, 25, 245-249.
7. Capraro, A.J., Wiley, J.F., Tucker, J.R. (2001) Severe intoxication from xylazine inhalation. Pediatric Emergency Care, 17, 447-448.
8. Samanta, A., Roffe, C., Woods, K. (1990) Accidental self administration of xylazine in a veterinary nurse. Journal of Postgraduate Medicine, 66, 244-245.
9. Spoerke, D.G., Hall, A.H., Grimes, M.J., Honea, B.N., Rumack, B.H. (1986) Human overdose with the veterinary tranquilizer xylazine. American Journal of Emergency Medicine, 4, 222-224.
10. Gallanosa, A.G., Spyker, D.A., Shipe, J.R., Morris, D.L. (1981) Human xylazine overdose: A comparative review with clonidine, phenothiazines, and tricyclic antidepressants. Clinical Toxicology, 18, 663-678.
11. Carruthers, S.G., Nelson, M., Wexler, H.R., Stiller, C.R. (1979) Xylazine hydrochloridine (Rompun) overdose in man. Clinical Toxicology, 15, 281-285.
12. Velez, L.I., Shepherd, G., Mills, L.D., Rivera, W. (2006) Systemic toxicity after an ocular exposure to xylazine hydrochloride. Journal of Emergency Medicine, 30, 407-410.
13. Lewis, S., O'Callaghan, C.L., Toghill, P.J. (1983) Clinical curio: Self medication with xylazine. British Medical Journal, 287, 1369.
14. Poklis, A., Mackell, M.A., Case, M.E. (1985) Xylazine in human tissue and fluids in a case of fatal drug abuse. Journal of Analytical Toxicology, 9, 234-236.
15. Briellmann, Th.A., Rickli, R., Jenny, C. (1994) A fatal Intoxication with xylazine. TIAFT Bulletin Case Notes, 24, 28-30.
16. Moore, K.A., Ripple, M.G., Sakinedzad, S., Levine, B., Fowler, D.R. (2003) Tissue distribution of xylazine in a suicide by hanging. Journal of Analytical Toxicology, 27, 110-112.
17. Arican, F.O., Okan, T., Badak, O., Guneri, S. (2004) An unusual presentation from xylazine-ketamine. Veterinary and Human Toxicology, 46, 324-325.
18. Wong, S.C., Curtis, J.A., Wingert, W.E. (2008) Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. Journal of Forensic Sciences, 53, 495-498.
19. Torruella, R.A. (2011) Xylazine (veterinary sedative) use in Puerto Rico. Substance Abuse, Treatment, Prevention, and Policy, 6, 7.
20. Ruiz, K., Perez, L., Peralta, O., Mattos, F., Rodriguez, J., Bloom, J. (2007) Emergences of xylazine as an adulterant of heroin in Puerto Rico. Society of Forensic Toxicologists 2007.
21. Ruiz, K., Silva, L.A., Chávez, C., Peralta, O., Bloom, J., Rodríguez, J. (2009) Common heroin adulterants in Puerto Rico: The emergence of xylazine. American Academy of Forensic Sciences, Annual Scientific Meeting.
22. Darke, S., Zador, D. (1996) Fatal heroin 'overdose': A review. Addiction, 91, 1765-1772.
23. Darke, S., Sunjic, S., Zador, D., Prolov, T. (1997) A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug and Alcohol Dependence, 25, 45-53.
24. Darke, S., Ross, J. (2000) Fatal heroin overdoses resulting from noninjecting routes of administration, NSW, Australia, 1992-1996. Addiction, 95, 569-573.
25. Warner-Smith, M., Darke, S., Lynskey, M., Hall, W. (2001) Heroin overdose: Causes and consequences. Addiction, 96, 1113-1125.
26. Hosztafi, S. (2003) Heroin, part III: The pharmacology of heroin. Acta Pharmaceutica Hungarica, 73, 197-205.
27. Chavez, C., Sanabria, D., Ruiz, K. (2009) Nine xylazine related deaths in Puerto Rico. Annual Scientific Meeting of American Academy of Forensic Sciences.
28. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
29. EU. (2002) Implementing Council Directive 96/23/EC concerning the performance of analytical method and interpretation of the results. Official Journal of the European Communities, 221, 8-36.
30. Maralikova, B., Weinmann, W. (2004) Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. Journal of Chromatography B, 811, 21-30.
31. Food and Drug Administration: U.S. Department of Health and Human Services. (2003) Guidance for Industry, Bioanalytical Method Validation. FDA, www.fda.gov/cder/guidance/4252fnl.pdf. Date accessed 30 October 2011.
32. Viswanathan, C.T., Bansal, S., Booth, B., DeStefano, A.J., Rose, M.J., Sailstad, J. et al. (2007) Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharmaceutical Research, 24, 1962-1973.
33. Rodríguez, N., Vargas, V.J., Panelli, J., Colón, H., Ritchie, B., Yamamura, Y. (2008) GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug and Alcohol Dependence, 96, 290-293.